Neighbouring countries
Bangladesh, Nepal, Bhutan, Myanmar and Sri Lanka

Plant under development · Partnerships across India
Build a national medicine business with a manufacturer focused on quality, dependable supply and long-term partnerships.
Distributors & C&F agents
We're appointing distributors and carrying & forwarding (C&F) agents across India ahead of launch. Partners will have a focused portfolio of 53 brands in high-demand therapy areas, consistent quality from a dedicated plant, and supply planning built around their market.
We're building the network ahead of launch. Appointments, supply and product availability will follow facility readiness and required approvals.
Third-party manufacturing
Pharma companies and marketing firms across India can have tablets, capsules and oral liquids manufactured under their own brand at our Durgapur plant, through third-party manufacturing or loan licensing.
Institutional supply
Hospitals, government procurement teams and affordable-medicine programmes can share their requirements as the facility moves toward launch and the necessary licences are secured.
Export partners
With WHO-GMP certification and COPP, we plan to supply regulated and semi-regulated markets, starting with neighbouring countries. Export supply will follow commissioning, registrations, applicable permissions and local partnerships.
Bangladesh, Nepal, Bhutan, Myanmar and Sri Lanka
Nigeria, Kenya, Mauritius and Madagascar
United Arab Emirates, Oman and Jordan
Investors & lenders
Investors and lending institutions can contact NRJS to discuss the greenfield project and request further information. Financial projections are shared directly with qualified parties and are not published on this website.
Project details can be requested directly. No financial figures are published on this website.
Request a project discussionThese answers describe current project status and future operating plans.
Yes. We're building a pan-India network of distributors and C&F agents, and our plant is on national road and rail corridors.
Yes. Third-party manufacturing and loan licensing for tablets, capsules and oral liquids will be open to pharma companies across India.
Durgapur, West Bengal, on NH-19 and the Delhi–Howrah rail main line.
Not yet. The facility is under development, and capacities and certifications shown are targets.